Treatment of Febrile Neutropenia in a 69-Year-Old Female with Metastatic Breast Cancer and Indwelling Catheter
The patient should immediately receive intravenous empiric antibiotic therapy with an anti-pseudomonal β-lactam agent such as cefepime (2g IV every 8 hours), meropenem, imipenem-cilastatin, or piperacillin-tazobactam. 1, 2, 3
Initial Assessment and Risk Stratification
This 69-year-old female with metastatic breast cancer presents with:
- Febrile neutropenia secondary to myelosuppression from chemotherapy
- Indwelling catheter with foul-smelling urine suggesting urinary tract infection
This patient should be classified as high-risk based on:
- Age >60 years
- Metastatic solid tumor
- Presence of indwelling catheter
- Signs of active infection (foul-smelling urine)
Immediate Diagnostic Workup
Before initiating antibiotics, obtain:
- At least 2 sets of blood cultures (one from each lumen of indwelling catheter and one from peripheral vein) 1
- Urine culture from the indwelling catheter 1
- Complete blood count with differential
- Serum creatinine, BUN, electrolytes, and liver function tests 1
- Chest radiograph if respiratory symptoms are present 1
Antibiotic Management
Initial Empiric Therapy
First-line treatment: Monotherapy with an anti-pseudomonal β-lactam:
- Cefepime 2g IV every 8 hours 3
- OR Meropenem 1g IV every 8 hours
- OR Imipenem-cilastatin 500mg IV every 6 hours
- OR Piperacillin-tazobactam 4.5g IV every 6-8 hours
Additional considerations:
Modifications Based on Clinical Scenario
Given the foul-smelling urine and indwelling catheter:
- Consider catheter removal or exchange if clinical condition does not improve within 48-72 hours 1
- If the patient has a history of colonization with resistant organisms (MRSA, VRE, ESBL-producing gram-negatives), modify therapy accordingly 1
Duration of Therapy
- Continue antibiotics until the patient has been afebrile for at least 2 days AND the neutrophil count is >500 cells/mm³ 2
- For documented urinary tract infection with an indwelling catheter, treat for 7-10 days 1, 3
- If fever resolves but neutropenia persists beyond 7 days, re-evaluate the need for continued antimicrobial therapy 3
Supportive Care
- Consider G-CSF (filgrastim) administration to reduce duration of neutropenia, particularly in high-risk patients 2
- Ensure adequate hydration and electrolyte balance
- Monitor renal function closely, especially if using nephrotoxic antibiotics
- Adjust antibiotic dosing based on renal function 3
Monitoring and Follow-up
- Daily assessment of fever trends, clinical status, and laboratory parameters 1
- Repeat blood cultures if fever persists
- Evaluate for subtle signs of infection at common sites (periodontium, pharynx, lower esophagus, lung, perineum, skin) 1
- Consider empiric antifungal therapy if fever persists after 4-7 days of appropriate antibacterial therapy 2
Common Pitfalls to Avoid
- Delayed antibiotic administration: Initiate antibiotics within 1 hour of presentation as delayed treatment increases mortality 2
- Inappropriate use of vancomycin: Only add if specific indications exist (catheter-related infection, skin/soft tissue infection, pneumonia, or hemodynamic instability) 1
- Failure to remove or exchange infected catheters: Consider catheter removal if infection persists despite appropriate antibiotics 1
- Premature discontinuation of antibiotics: Continue until both fever resolution AND neutrophil recovery 2
- Overlooking fungal infections: Consider empiric antifungal therapy if fever persists after 4-7 days of antibiotics 2
This patient's presentation with febrile neutropenia, metastatic cancer, and signs of urinary tract infection with an indwelling catheter represents a medical emergency requiring prompt intervention to reduce morbidity and mortality.